Trialsai

Trials.ai leverages AI to manage clinical trials. We’re focused on Study Design & Execution for Sponsors & CRO’s & Sites.

Trials.ai is leveraging artificial intelligence to fix the two root causes of failure in clinical trials: Study Design & Execution – because patients don’t have time to wait. Every year great research, powerful drugs and innovative devices fail clinical trials because of poor protocols and lack of intelligent tools to conduct trials. Silo'd systems, endless spreadsheets and lack of real-time data wouldn't cut it in other industries, why should healthcare settle? ​Trials.ai is developed with one purpose: to get effective treatments to patients faster by accelerating trials. Our unique approach leverages AI upstream to improve study designs and machine learning to make trial execution smarter, faster and easier for researchers and participants. Based in San Diego, California, Trials.ai launched by Kim Walpole in 2015.